All Type of News
MFDS provides foreign precedents about 30 pharmaceutical patents
In order for Korean pharmaceutical companies to be preventive and responsive on patent disputes, the Ministry of Food and Drug Safety(MFDS) announced to provide the ‘Foreign Judicial Precedents of Pharmaceutical Paten...
MOHW promises policies about public medical services and industry development to the president
The Ministry of Health and Welfare(MOHW) will improve chronic disease management services mainly from local clinics to the government’s public medical profile and nurture the pharmaceutical industry ahead of the Fourt...
Dong-A ST concludes co-sale agreement of antihypertensive ‘Edarbi’ with Takeda
Dong-A ST announced on the 30th that conclusion of a joint sale and marketing agreement of ‘Edarbi,’ an ARB(angiotensin II receptor blocker) antihypertensive, with Takeda Pharmaceuticals Korea.
Under the agreement, D...
Daewoong Bio file appeal, “GLIATAMIN and GLIATILIN has no similarity in trademark”
Daewoong Bio said on the 30th “Cognition-enhancing GLIATAMIN and Italfarmaco’s GLIATILIN have no similarity in appearance, name and concept. We’ll immediately file an appeal.”
It was the company’s official position a...
Daewoong and Kolmar nominated best as cosmetic company in ‘World Class 300 Companies’
Daewoong Pharmaceutical and Korea Kolmar were ranked as a cosmetic manufacturer and Haesung Optics and Alpinion Medical Systems were ranked as a biotech company in the ‘World Class 300 Companies’ for the pharmaceutica...
Listed pharmas had more than KRW 100 million annual wage differences between officers and employees
Annual wage differences between employees and officers working for a listed pharmaceutical company were reportedly more than KRW 100 million.
Yakup Shinmoon(www.yakup.com) analyzed KOSPI and KOSDAQ listed pharmaceuti...
Pouring ‘Tamiflu’ generics raise concerns in pharmacy circles
Pouring generic drugs in the market, caused by recent patent expirations of original drugs, such as Tamifly, are expected to raise concerns in the pharmacy circles.
When it comes to ‘Tamiflu, an influenza treatment w...
1 of 5 listed pharmas has ‘poor’ financial structure
1 of 5 listed pharmaceutical companies reportedly have a debt ratio more than 100%, evaluated to have poor financial structure.
Yakup Shinmoon(www.yakup.com) analyzed 61 KOSPI and KOSDAQ listed pharmaceutical compani...
Hanmi Pharm manufactures medicines the most, Celltrion ranked top in APIs
A pharmaceutical company which manufactured the largest amount of medicines was Hanmi Pharm last year.
Medicine = The Top 20 Manufacturers’ Manufacturing Performance by Manufacturing Type’ totaled by the Korea Pharma...
‘Large competition’ expected among pharmas over tetravalent flu vaccines
While an influenza vaccine program will start this September, competition for tetravalent flu vaccines is expected to get fiercer than the last year.
The Ministry of Food and Drug Safety(MFDS) revealed information ab...
